News & Updates

Abatacept, TNFi reduce CVD risk in RA patients

19 May 2021

Treatment with abatacept or tumour necrosis factor-α inhibitor (TNFi) leads to a lower risk of cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA) as compared with conventional synthetic disease-modifying antirheumatic drugs (csDMARD), suggests a study.

Abatacept, TNFi reduce CVD risk in RA patients

19 May 2021

Smokers, obese people at greater risk of RA-ILD

17 May 2021 by

Individuals with obesity, high-level C-reactive protein (CRP), and poor functional status are more likely to develop incident rheumatoid arthritis-related interstitial lung disease (RA-ILD), a recent study has found. Smoking 30 pack-years or more may also substantially increase the risk of RA-ILD, while lower levels of smoking do not.

Smokers, obese people at greater risk of RA-ILD

17 May 2021

Faecal microbiota transplantation dashes hope in psoriatic arthritis

16 May 2021

Faecal microbiota transplantation (FMT) does not appear to be beneficial in the treatment of active peripheral psoriatic arthritis, with a recent study showing that although FMT does not increase the incidence of serious adverse events, it is inferior to sham.

Faecal microbiota transplantation dashes hope in psoriatic arthritis

16 May 2021

Anticoagulant use may exert unfavourable effects on bone health

14 May 2021

Individuals who use anticoagulants appear to have decreased bone density and quality—an effect that is seen with direct-acting oral anticoagulants (DOACs) but more pronounced with warfarin, a study reports.

Anticoagulant use may exert unfavourable effects on bone health

14 May 2021

BMD assessment helps pinpoint Asian women at risk of ASCVD

12 May 2021 by

Low bone mineral density (BMD), on its own, is predictive of a heightened risk of atherosclerotic cardiovascular disease (ASCVD) in women, as well as provides an incremental prognostic value over age and other clinical risk factors, as shown in a study from Korea.

BMD assessment helps pinpoint Asian women at risk of ASCVD

12 May 2021

Etanercept does better than methotrexate at keeping RA in remission

11 May 2021 by

Rheumatoid arthritis (RA) patients achieving remission with the combination of methotrexate plus etanercept may be able to maintain their status by stopping the former and continuing treatment with the latter, as shown in the SEAM-RA* trial. In the maintenance setting, etanercept monotherapy does a better job than methotrexate alone and as good as the combination of the two drugs.

Etanercept does better than methotrexate at keeping RA in remission

11 May 2021

Continuous anifrolumab exposure safe, produces sustained SLE disease activity improvement

11 May 2021

In the treatment of patients with systemic lupus erythematosus (SLE), long-term use of the type I interferon inhibitor anifrolumab leads to sustained improvements in disease activity, quality of life, and serologic measures, according to the results of the open-label extension study.

Continuous anifrolumab exposure safe, produces sustained SLE disease activity improvement

11 May 2021

NSAID use does not predispose OA patients to COVID-19 infection

10 May 2021 by

Patients with osteoarthritis (OA) can safely continue taking their nonsteroidal anti-inflammatory drugs (NSAIDs), which have been shown to have a null effect on the risk of contracting COVID-19 or all-cause mortality, as reported in a study.

NSAID use does not predispose OA patients to COVID-19 infection

10 May 2021

In-person occupational therapy, app-delivered exercises confer benefits for hand disability

01 May 2021

For systemic sclerosis patients, occupational therapy and/or performing exercises delivered via a mobile application can help reduce hand disability, as shown in a recent study.

In-person occupational therapy, app-delivered exercises confer benefits for hand disability

01 May 2021

Excess weight tied to more severe psoriatic arthritis in women

29 Apr 2021

In a tightly monitored treatment setting, female patients with psoriatic arthritis (PsA) have greater disease severity than their male peers, as shown in a study. Being overweight is a notable risk factor for higher disease activity in women, but not in men.

Excess weight tied to more severe psoriatic arthritis in women

29 Apr 2021

News & Updates

Filter by Specialty:

Specialty:

Abatacept, TNFi reduce CVD risk in RA patients

Abatacept, TNFi reduce CVD risk in RA patients

Smokers, obese people at greater risk of RA-ILD

Smokers, obese people at greater risk of RA-ILD

Faecal microbiota transplantation dashes hope in psoriatic arthritis

Faecal microbiota transplantation dashes hope in psoriatic arthritis

Anticoagulant use may exert unfavourable effects on bone health

Anticoagulant use may exert unfavourable effects on bone health

BMD assessment helps pinpoint Asian women at risk of ASCVD

BMD assessment helps pinpoint Asian women at risk of ASCVD

Etanercept does better than methotrexate at keeping RA in remission

Etanercept does better than methotrexate at keeping RA in remission

Continuous anifrolumab exposure safe, produces sustained SLE disease activity improvement

Continuous anifrolumab exposure safe, produces sustained SLE disease activity improvement

NSAID use does not predispose OA patients to COVID-19 infection

NSAID use does not predispose OA patients to COVID-19 infection

In-person occupational therapy, app-delivered exercises confer benefits for hand disability

In-person occupational therapy, app-delivered exercises confer benefits for hand disability

Excess weight tied to more severe psoriatic arthritis in women

Excess weight tied to more severe psoriatic arthritis in women